Emergent BioSolutions Joins Effort to Combat National Public Health Threat From Opioid Overdose Through Acquisition of Adapt Pharma and Its Flagship Product NARCAN® (naloxone HCl) Nasal Spray

World News: . []

GAITHERSBURG Md Aug 28 2018 GLOBE NEWSWIRE -- Emergent BioSolutions Inc NYSE EBS LINK  today that it has entered into an agreement to LINK  Adapt Pharma and its flagship LINK  NARCAN naloxone HCl Nasal Spray the first and on ly need...

More news and information about Emergent BioSolutions

Published By:

Globe Newswire: 21:31 GMT Tuesday 28th August 2018

Published: .

Search for other references to "emergent" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us